Insider Transactions in Q1 2024 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 05
2024
|
Gilmore Neil O'Neill CEO |
SELL
Open market or private sale
|
Direct |
77,824
-19.2%
|
$700,416
$9.42 P/Share
|
|
Mar 04
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
20,327
-12.56%
|
$182,943
$9.42 P/Share
|
|
Mar 02
2024
|
Erick Lucera EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
61,266
+19.75%
|
-
|
|
Mar 02
2024
|
Gilmore Neil O'Neill CEO |
BUY
Grant, award, or other acquisition
|
Direct |
275,125
+22.11%
|
-
|
|
Mar 02
2024
|
Linda Burkly EVP, CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
39,855
+20.61%
|
-
|
|
Mar 02
2024
|
Baisong Mei EVP, CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
89,815
+17.34%
|
-
|